The mutation rate of the NAV2 gene was 8.6% (31/360) in TCGA–Liver Hepatocellular Carcinoma (LIHC) data, and the NAV2 gene was reported to be associated with hepatitis but not HCC [39]. Here, NAV2 is linked to hepatocellular carcinoma.